On 04 February 2026, Sipai Health Technology Co., Ltd. (00314) disclosed a repurchase of 2,640,000 ordinary shares, which have been designated as treasury shares. After the repurchase, the number of issued shares (excluding treasury shares) stands at 739,415,514, while treasury shares total 26,162,600, bringing the total number of issued shares to 765,578,114.

According to the announcement, the repurchased shares were acquired on the Hong Kong Stock Exchange at a price ranging from HKD 2.44 to HKD 2.60 per share, with an aggregate consideration of HKD 6,726,124. The transaction was executed under a repurchase mandate dated 20 June 2025, which authorized up to 75,022,471 shares to be bought back. As of the date of disclosure, 11,982,800 shares have been repurchased under this mandate, accounting for approximately 1.597% of the issued shares on the date the mandate was granted.

The announcement further notes a moratorium period on the issuance of new shares or the sale or transfer of treasury shares until 06 March 2026, in accordance with relevant listing rules. The disclosure confirms that the transaction complied with all applicable regulations and that the repurchase has been duly authorized and executed.